Pfizer Stock News Today (PFE): Texas ADHD Settlement, New Antibody Partnership and Obesity Push – November 19, 2025
Pfizer (NYSE: PFE) headlines today include a $41.5 million ADHD drug settlement with Texas, a new antibody discovery deal with Nona Biosciences, and fresh guidance on cost cuts and obesity drugs from the Jefferies Healthcare Conference — here’s what it all means for PFE stock on November 19, 2025. Key Takeaways for Pfizer Investors Today Pfizer Stock Today: How PFE Is Trading on November 19, 2025 Ahead of and shortly after the open on Wednesday, November 19, 2025, Pfizer shares (NYSE: PFE) are hovering around the $25–26 range. MarketWatch shows pre‑market trading near $25.37, modestly below the prior close at